Aadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)PRNewsWire • 10/03/23
Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive OfficerPRNewsWire • 10/02/23
Aadi Bioscience, Inc. (AADI) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/09/23
Aadi Bioscience Announces Financial Results for the Second Quarter 2023 and Provides Corporate UpdatePRNewsWire • 08/09/23
Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingPRNewsWire • 05/25/23
Aadi Bioscience, Inc. (AADI) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/10/23
Aadi Bioscience Announces Financial Results and Operational Update for the First Quarter 2023 and Provides Update on PRECISION 1 Tumor Agnostic TrialPRNewsWire • 05/10/23
Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingPRNewsWire • 04/26/23
Aadi Bioscience to Present Multiple Posters on nab-Sirolimus at the 2023 American Association for Cancer Research (AACR) Annual MeetingPRNewsWire • 04/14/23
Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2023PRNewsWire • 04/06/23
Aadi Bioscience, Inc. (AADI) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 03/28/23
Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2022 and Provides Corporate UpdatePRNewsWire • 03/28/23
Aadi Bioscience Presents Clinical Data from PRECISION 1 and AMPECT Trials at the Society of Gynecological Oncology (SGO) Annual Meeting on Women's CancerPRNewsWire • 03/26/23
Aadi Bioscience to Report Fourth Quarter and Full-Year 2022 Results and Corporate UpdatePRNewsWire • 03/15/23